Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/6955 stock hub

HKG/6955 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/6955is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/6955

In the news

Latest news · HKG/6955

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E513.5

P25 10.7P50 17.9P75 38.5

ROE0.3

P25 -14.7P50 2P75 9.4

ROIC0.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/6955 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

CNY

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	714
Employees Change	-46%
Employees Change Percent	-6.05
Enterprise value	HKD 3.7B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	HKD 4.1B
Price	HKD 6.56
Price currency	HKD
Sector	Healthcare
Sic	2836
Symbol	hkg/6955
Website	https://www.boan-bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.19%
EV Earnings	464.94x
EV/EBIT	101.53x
EV/EBITDA	43.75x
EV/Sales	4.23x
P/B ratio	1.34x
P/E ratio	513.53x
P/S ratio	4.67x
PE Ratio3 Y	239.84x
PE Ratio5 Y	215.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.17%
EBITDA Margin	9.67%
Gross margin	71.66%
Gross Profit	HKD 625.9M
Gross Profit Growth	3.65%
Gross Profit Growth Q	7.63%
Gross Profit Growth3 Y	1.78%
Gross Profit Growth5 Y	9.02%
Net Income	HKD 7.9M
Net Income Growth	-90.24%
Net Income Growth3 Y	-51.29%
Pretax Margin	0.91%
Profit Margin	0.91%
ROA	0.59
Roa5y	-4.13
ROCE	1
ROE	0.33
Roe5y	-9.59
ROIC	0.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.78%
Cagr3y	-27.13%
EPS Growth	-90.91
EPS Growth3 Y	-53.24
Revenue Growth	8.06x
Revenue Growth Q	7.72x
Revenue Growth3 Y	2.92x
Revenue Growth5 Y	7.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.22
Assets	HKD 4.6B
Cash	HKD 1.3B
Current Assets	HKD 2.3B
Current Liabilities	HKD 995.7M
Debt	HKD 871.6M
Debt EBITDA	HKD 10.32
Debt Equity	HKD 0.29
Equity	HKD 3B
Interest Coverage	0.85
Liabilities	HKD 1.5B
Long Term Assets	HKD 2.3B
Long Term Liabilities	HKD 546.4M
Net Cash	HKD 386.3M
Net Cash By Market Cap	HKD 9.46
Net Debt EBITDA	HKD -4.57
Net Debt Equity	HKD -0.13
Tangible Book Value	HKD 1.5B
Tangible Book Value Per Share	HKD 2.35
WACC	4.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.33
Inventory Turnover	1.49
Net Working Capital	HKD 542.9M
Quick ratio	2.08
Working Capital	HKD 1.3B
Working Capital Turnover	HKD 1.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.76%
200-day SMA	10.58
3Y total return	-61.32%
50-day SMA	6.98
50-day SMA vs 200-day SMA	50under200
All Time High	40
All Time High Change	-83.6%
All Time High Date	2023-03-15
All Time Low	6.12
All Time Low Change	7.19%
All Time Low Date	2026-03-31
ATR	0.29
Beta	0.05
Beta1y	0.77
Beta2y	1
Ch YTD	-23.19
High	6.72
High52	19.9
High52 Date	2025-08-08
High52ch	-67.04%
Low	6.5
Low52	6.12
Low52 Date	2026-03-31
Low52ch	7.19%
Ma50ch	-5.99%
Price vs 200-day SMA	-38.01%
RSI	40.87
RSI Monthly	38.3
RSI Weekly	32.6
Sharpe ratio	-0.49x
Sortino ratio	-0.7
Total Return	-7.4%
Tr YTD	-23.19
Tr1m	-6.02%
Tr1w	-6.82%
Tr3m	-14.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 36.4M
Operating Income Growth	-48.75
Operating Income Growth3 Y	18.15
Operating margin	4.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,538,570%
Shares Insiders	3.46%
Shares Institutions	15.18%
Shares Out	622,333,694
Shares Qo Q	0.43%
Shares Yo Y	7.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,564,991.4x
Bv Per Share	4.9
Ch1m	-6.02
Ch1w	-6.82
Ch1y	-29.76
Ch3m	-14.14
Ch3y	-61.32
Ch6m	-33.94
Change	-1.5%
Change From Open	-1.94
Close	6.66
Days Gap	0.45
Depreciation Amortization	49,750,978.5
Dollar Volume	25,207,639.7
Earnings Date	2026-05-27
EBIT	HKD 36.4M
EBITDA	HKD 84.5M
EPS	HKD 0.01
F Score	4
Fiscal Year End	December
Founded	2,013
Graham Number	1.23391
Graham Upside	-81.19
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 0.07
Lynch Upside	-98.95
Ma150	8.89
Ma150ch	-26.19%
Ma20	6.91
Ma20ch	-5.08%
Next Earnings Date	2026-05-27
Open	6.69
Position In Range	27.27
Ppne	681,774,843.6
Price Date	2026-05-08
Price EBITDA	HKD 48.32
Ptbv Ratio	2.79
Relative Volume	1.08x
Revenue	873,357,964x
Tr6m	-33.94%
Volume	3,842,628

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/6955 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/6955 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/6955?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.2%

Share of float held by funds and institutions

Insider ownership

+3.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.4%

Negative means the company is buying back shares.

Technical

HKG/6955 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

-38.0%

50/200-day relationship not available

Beta (5Y)

0.05

Less volatile than the market

Sharpe ratio

-0.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/6955

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/6955 stock rating?

hkg/6955 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/6955 analysis?

The full report lives at /stocks/hkg/6955/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/6955?

The latest report frames hkg/6955 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/6955 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.